Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Hisamitsu Pharmaceutical Co ( (JP:4530) ) just unveiled an announcement.
Hisamitsu Pharmaceutical Co. announced the acquisition of 156,800 of its own shares, amounting to 674,001,100 yen, through open market purchases on the Tokyo Stock Exchange. This move is part of a broader strategy approved by the board to acquire up to 3 million shares, aiming to enhance shareholder value and optimize capital structure.
The most recent analyst rating on (JP:4530) stock is a Buy with a Yen4700.00 price target. To see the full list of analyst forecasts on Hisamitsu Pharmaceutical Co stock, see the JP:4530 Stock Forecast page.
More about Hisamitsu Pharmaceutical Co
Hisamitsu Pharmaceutical Co., Inc., headquartered in Tosu City, Saga Prefecture, is a company involved in the pharmaceutical industry. It focuses on the production and distribution of pharmaceutical products, with a significant emphasis on transdermal drug delivery systems.
Average Trading Volume: 182,838
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen313B
For an in-depth examination of 4530 stock, go to TipRanks’ Overview page.